Pfizer Dodges Challenge to Its Board
Pfizer avoids board nominations from Starboard as proxy fight rolls on: Bloomberg
Following a tough opening salvo from Starboard Value last fall, Pfizer is getting a chance to catch its breath in the activist investor’s unfolding proxy fight. | Activist Investor Starboard Value stopped short of nominating any directors to Pfizer’s board ahead of a Jan.
Bitcoin miner Riot Platforms (RIOT) finds itself a target of a second activist investor, with Reuters reporting investment ...
GlobalData on MSN10d
Starboard Value acquires 7.7% stake in chipmaker QorvoActivist investor Starboard Value has acquired a 7.7% stake in Qorvo, a NASDAQ-listed maker of radio frequency and power ...
5don MSN
Starboard is a very successful activist investor and has extensive experience helping companies focus on operational ...
Qorvo shares jumped 11% Friday when hedge fund Starboard Value made a significant investment in the maker of radio ...
D.E. Shaw’s stake in Riot Platforms, alongside Starboard’s involvement, signals potential changes for the Bitcoin mining giant.
Investment firm D.E. Shaw has built a position in Riot Platforms and may push it to make changes, two sources familiar with ...
Starboard last year took a $1 billion stake in Pfizer, looking to turn the pharma around after alleged severe shortcomings by ...
Activist Investor Starboard Value Takes 7.7% Stake in Chipmaker Qorvo (Reuters) -Starboard Value has built a 7.7% stake in Qorvo, the chipmaker revealed in a filing on Friday, as the activist ...
Qorvo (QRVO) shares fell 0.5% in premarket trading on Friday, even as Mizuho Securities upped its earnings estimates on the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback